NRx Pharmaceuticals Files Counterclaim Against its Former Co

/PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP) filed a lawsuit on Monday against Relief Therapeutics (SIX: RLF, OTCQB: RLFTF, RLFTY), its former...

Related Keywords

Texas , United States , Miami , Florida , Radnor , Powys , United Kingdom , Israel , Washington , Daniele Troy , Francis Collins , Whit Clay , Sherry Glied , Raghuram Selvaraju , Jacobo Elgozy , Hc Wainwright Bioconnect , Chaim Hurvitz , Jack Weinstein , Jonathan Javitt , Nrx Pharmaceuticals , Phd Us Army , Israel Ministry Of Defense , Novartis , Pfizer , Prnewswire Nrx Pharmaceuticals Nasdaq , Source Nrx Pharmaceuticals , York State Supreme Court , European Union , Allergan , Us Department Of Health , Israel Institute For Biological Research , National Institutes Of Health , Biomedical Advanced Research , Human Services , Drug Administration , United States National Security Advisor , Development Authority , Nrx Pharmaceuticals Inc , Exchange Commission , National Institutes For Allergy , Teva International Group , Us Department Of Defense , Us National Institutes Of Health , Sloane Company , Relief Therapeutics , New York State Supreme , National Institutes , Prof Jonathan Javitt , Federal Right , Try Act , Bioconnect Virtual Healthcare Conference , United States Federal , Good Manufacturing Practices , Infectious Diseases , Chief Medical Officer , New York State Supreme Court , Israel Institute , Biological Research , Israel Ministry , Fast Track , Medical Countermeasures , Breakthrough Therapy Designation , Special Protocol Agreement , Biomarker Letter , Chief Counsel , United States National Security , Vasoactive Intestinal Polypeptide , Sami Said , Securities Litigation Reform Act ,